Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.

Li B, Du C, Zhou L, Bi Y, Wang X, Wen L, Guo Z, Song Z, Yang R.

Clin Vaccine Immunol. 2012 Feb;19(2):228-34. doi: 10.1128/CVI.05559-11. Epub 2011 Dec 21.

2.

Protecting against plague: towards a next-generation vaccine.

Williamson ED, Oyston PC.

Clin Exp Immunol. 2013 Apr;172(1):1-8. doi: 10.1111/cei.12044. Review.

3.

Plague vaccines and the molecular basis of immunity against Yersinia pestis.

Quenee LE, Schneewind O.

Hum Vaccin. 2009 Dec;5(12):817-23. Epub 2009 Dec 1. Review.

PMID:
19786842
4.

Prospects for new plague vaccines.

Feodorova VA, Corbel MJ.

Expert Rev Vaccines. 2009 Dec;8(12):1721-38. doi: 10.1586/erv.09.129. Review. Erratum in: Expert Rev Vaccines. 2010 Jan;9(1):110.

PMID:
19943765
5.

Immune defense against pneumonic plague.

Smiley ST.

Immunol Rev. 2008 Oct;225:256-71. doi: 10.1111/j.1600-065X.2008.00674.x. Review.

6.

Rational considerations about development of live attenuated Yersinia pestis vaccines.

Sun W, Curtiss R.

Curr Pharm Biotechnol. 2013;14(10):878-86. Review.

7.

Kinetics of memory B cell and plasma cell responses in the mice immunized with plague vaccines.

Zhang X, Wang Q, Bi Y, Kou Z, Zhou J, Cui Y, Yan Y, Zhou L, Tan Y, Yang H, Du Z, Han Y, Song Y, Zhang P, Zhou D, Yang R, Wang X.

Scand J Immunol. 2014 Mar;79(3):157-62. doi: 10.1111/sji.12146. Review.

8.

Protective immunity against plague.

Cornelius C, Quenee L, Anderson D, Schneewind O.

Adv Exp Med Biol. 2007;603:415-24. Review.

PMID:
17966437
9.

Cell-mediated defense against Yersinia pestis infection.

Smiley ST.

Adv Exp Med Biol. 2007;603:376-86. Review.

PMID:
17966434
10.

Developing live vaccines against plague.

Sun W, Roland KL, Curtiss R 3rd.

J Infect Dev Ctries. 2011 Sep 14;5(9):614-27. Review.

11.

Live-attenuated Yersinia pestis vaccines.

Wang X, Zhang X, Zhou D, Yang R.

Expert Rev Vaccines. 2013 Jun;12(6):677-86. doi: 10.1586/erv.13.42. Review.

PMID:
23750796
12.

Current challenges in the development of vaccines for pneumonic plague.

Smiley ST.

Expert Rev Vaccines. 2008 Mar;7(2):209-21. doi: 10.1586/14760584.7.2.209. Review.

13.

[A molecular basis of the plague vaccine development].

Dentovskaia SV, Kopylov PKh, Ivanov SA, Ageev SA, Anisimov AP.

Mol Gen Mikrobiol Virusol. 2013;(3):3-12. Review. Russian.

PMID:
24364139
14.

Second and third generation plague vaccines.

Titball RW, Williamson ED.

Adv Exp Med Biol. 2003;529:397-406. Review. No abstract available.

PMID:
12756798
15.

Plague Vaccine Development: Current Research and Future Trends.

Verma SK, Tuteja U.

Front Immunol. 2016 Dec 14;7:602. doi: 10.3389/fimmu.2016.00602. eCollection 2016. Review.

17.

[CONTEMPORARY TENDENCIES IN CONSTRUCTING RECOMBINANT VACCINES FOR SPECIFIC PROPHYLAXIS OF PLAGUE].

Mikshis NI, Kudryavtseva OM, Kutyrev VV.

Zh Mikrobiol Epidemiol Immunobiol. 2015 May-Jun;(3):116-26. Review. Russian.

PMID:
26259281
18.

Plague vaccines: current developments and future perspectives.

Feodorova VA, Motin VL.

Emerg Microbes Infect. 2012 Nov;1(11):e36. doi: 10.1038/emi.2012.34. Epub 2012 Nov 7. Review.

19.

YopM and plague.

Straley SC.

Adv Exp Med Biol. 2012;954:247-52. doi: 10.1007/978-1-4614-3561-7_31. Review. No abstract available.

PMID:
22782770

Supplemental Content

Support Center